IMMUNIC, INC. — Director's Dealing 2024

Jan 19, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2024-01-17

Reporting Person: Vitt Daniel (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-17	Stock Option	$1.21	A	1160000	Acquired	2034-01-17	Common Stock (1160000)	Direct

Footnotes

F1: 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months.